The Paradigm Shift in Biomarker Testing to Refine mCRC Treatment Strategies

Wednesday, November 20, 2024

9:00 AM – 9:50 AM PST

Location: 202 - 204, Level 2

Corporate Workshop Speaker(s)

Christopher Lieu, MD

Professor of Medicine | Director, GI Medical Oncology
University of Colorado Cancer Center, Colorado, United States
Eric Vail, MD (he/him/his)

Assistant Professor of Pathology | Director, Molecular Pathology| Director, MGP Fellowship Program | Department of Pathology and Laboratory Medicine
Cedars-Sinai Medical Center
Los Angeles, California, United States

The evolving landscape of actionable biomarkers continues to refine personalized treatment strategies in metastatic colorectal cancer. However, multiple challenges with biomarker testing can impede patient access to these precision therapeutic approaches.

In this workshop, Christopher Lieu, MD and Eric Vail, MD will review the evolving biomarker-driven treatment landscape, current challenges, testing best practices and MDT patient management approaches to support the delivery of precision medicine for patients diagnosed with metastatic colorectal cancer.